Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study

Clicks: 176
ID: 273576
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #280 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Treatment of moderate to severe coronavirus disease 2019 (COVID-19) with remdesivir and dexamethasone was associated with a lower risk of mechanical ventilation
Reference Key
thomasclinicalimproved Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Benfield, Thomas;Bodilsen, Jacob;Brieghel, Christian;Harboe, Zitta Barrella;Helleberg, Marie;Holm, Claire;Israelsen, Simone Bastrup;Jensen, Janne;Jensen, Tomas Østergaard;Johansen, Isik Somuncu;Johnsen, Stine;Lindegaard, Birgitte;Lundgren, Jens;Meyer, Christian Niels;Mohey, Rajesh;Pedersen, Lars Møller;Nielsen, Henrik;Nielsen, Stig Lønberg;Obel, Niels;Omland, Lars Haukali;Podlekareva, Daria;Poulsen, Birgitte Klindt;Ravn, Pernille;Sandholdt, Haakon;Starling, Jonathan;Storgaard, Merete;Søborg, Christian;Søgaard, Ole Schmeltz;Tranborg, Torben;Wiese, Lothar;Christensen, Hanne Rolighed;
Journal clinical infectious diseases
Year Year not found
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.